Evaluation of the anti-inflammatory and analgesic activities of Vitex doniana leaves

African Journal of Biotechnology

Volumn 5, Issue 20, 2006, Pages 1929-1935

  Iwueke, A V ^a   Nwodo, O F C ^b   Okoli, C O ^b  

^a FEDERAL UNIVERSITY OF TECHNOLOGY   (Nigeria)

^b UNIVERSITY OF NIGERIA   (Nigeria)

Author keywords

Analgesic; Anti inflammatory; Ulcerogenic activity; Vitex doniana

Indexed keywords

AGAR; ALKALOID; ARACHIDONIC ACID; FLAVONOID; GLYCOSIDE; PHOSPHOLIPASE A2; PLANT EXTRACT; PROSTAGLANDIN SYNTHASE; TANNIN; UNCLASSIFIED DRUG; VITEX DONIANA EXCTRACT;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DOSE RESPONSE; ENZYME INHIBITION; HEMOLYSIS; LD 50; MUSCLE HYPOTONIA; NONHUMAN; PAW EDEMA; PHYTOCHEMISTRY; RAT; STOMACH ULCER;

VERBENACEAE; VITEX DONIANA;

EID: 33750932818     PISSN: 16845315     EISSN: 16845315     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Agunu A., Yusuf S, Andrew GO, Zezi AU, Abdurahman EM (2005). Evaluation of five medicinal plants used in diarrhoea treatment in Nigeria. J .Ethnopharmacol. (Abstract) (Epub ahead of print)
2. Atawodi SE (2005). Comparative in vitro trypanocidal activities of petroleum ether, chloroform, methanol, and aqueous extracts of some Nigerian savannah plants. Afr. J. Biotech. 4(2): 177-182.
3. Atawodi SE, Bulus T, Ibrahim S, Ameh DA., Nok AJ, Mamman M, Galadima M (2003). In vitro trypanocidal effect of methanolic extract of some Nigerian savannah plants. Afr. J. Biotech. 2(9): 317-321.
4. Bouquet A, Cave A., Paris R (1971). Plantes medicinales du Congo-Brazzaville (III) plantes medicinales et phytotherapie. Tome. 5 (2):154-158.
5. Cashin CH, Darson W, Kitchen EA (1979). The Pharmacology of bernoxaprofen (2,4-chlorophenyl-methyl-5-benzoxazole acetic acid)LRC, L3694, a new compound with anti-inflammatory activity apparently unrelated to inhibition of PG synthetase. J. Pharm. Pharmacol. 29: 330-336.
6. Chou CT (1997). The anti-inflammatory effect of Tripterygium wilfordii Hook F on adjuvant-induced paw edema in rats and inflammatory mediators release. Phytother. Res. 11:152-154
7. Cousins D, Huffman MA. (2002). Medicinal properties in the diet of gorillas: an ethno-pharmacological evaluation. Afr. Stud. Monog. 23(2): 65-89.
8. Dray A (1995). Inflammatory mediators of pain. Br. J. Anaesth. 75: 125-131.
9. Etta EN (1984). Preliminary investigation into the anti-diarrhoeal activity of extracts of the leaves of Vitex doniana Sweet. B. Pharm. Thesis, Pharmacology, University of Nigeria, Nsukka, Nigeria.
10. Ezekwesili C, Nwodo OFC (2000). Anti-inflammatory activity of Vignia ungiculata seed extract. J. Med. Lab. Scs. 9, 141
11. th edition. Lange Medical Books/McGraw-Hill, New York. 311-325.
12. Flower RJ, Cheung HS, Cushman DW (1973). Quantitative determination of prostglandin and malondialdehyde formed by the arachidonate oxygenase (prostaglandin synthetase) system of bovine serum vesicle. Prostaglandin. 4,325-341.
13. Flower RJ, Vane J R (1974). Inhibition of prostaglandins synthesis. Biochem. Pharmacol. 23:1439-1450.
14. th edition. Lange Medical Books/McGraw-Hill, New York. pp. 596-623.
15. Gandhisan R, Thamaraichelvan A, Baburaj C (1991). Anti-inflammatory action of Lannea coromandelica HRBC membrane stabilization. Fitoterapia. 62 81-83.
16. Gebhart GF, McCormack KJ (1994). Neuronal plasticity; implications for pain therapy. Drugs 47 (Suppl 5);1-47.
17. st edition Chapman and Hall, London.
18. Irvine FR (1961). Woody plants of Ghana. Oxford University press, London. p.761-762.
19. Iwu MM (1993). Handbook of African medicinal plants. CRC Press, London.
20. Jager AK, Hutchings A, van Staden J (1996). Screening of Zulu medicinal plants for prostaglandin synthesis inhibition. J. Ethnopharmacol.52: 95-100.
21. Janssen PAJ, Jageneau AH (1957). A new series of potent analgesics: Dextro 2,2-diphenyl-3-methyl-H-morholino-butryprolidine and related amides. Part 1. Chemical structure and pharmacological activity. J. Pharm. Pharmacol. 9:38.
22. Konttiene, YT, Kemppinen P, Segerberg M, Hukkanen M, Rees R, Santavirta S, Sorsa T, Pertovaara A, Polak JM (1994). Peripheral and spinal neural mechanisms in arthritis with particular reference to treatment of inflammation and pain. Arthritis Rheum. 37:965-982.
23. Lorke D (1983). A new approach to practical acute toxicity testing. Arch. Toxicol. 54:275-287.
24. McGaw LJ, Anna K Jager, Johannes van Staden (1997). Prostaglandins synthesis inhibitory activity in Zulu, Xhosa and Sotho medicinal plants.Phytother. Res. 11:113-117.
25. Morimoto S, Kazuna S, Kawai K (1979). Effects of some anti-rheumatic agents on copper-catalysed thermal aggregation of gamma albulin. Agents Actions. 9: 375-380.
26. Murugesh N, Vember S, Damondaran C (1981) Studies on erythrocyte membrane IV: in vitro haemolytic activity of oleander extract. Toxicol. Lett. 8: 33-38.
27. Nishihara T F (1995). Feeding ecology of western lowland gorillas in the Nouabale-Ndoki National Park, Congo. Primates. 36(2): 151-168.
28. Nugteren DH, Beerthius RK, Vandorp DA (1966) Enzymic conversion of all-8,11,14-eicosatrienoic acid into prostraglandin E. Rec. Trav. Chin. Pays-Bas. 85: 1757-1765.
29. Nwodo OFC (1981). Elucidation of the nature of some pharmacologically active substances extractible from the seeds of Abrus precatorius. .A PhD thesis submitted to the Department of Biochemistry, University of London.
30. Olusola L, Zebulon SC, Okoye FU (1997). Effects of Vitex doniana stem bark on blood pressure. Nig. J. Nat. Prod. Med. 1: 19-20.
31. Oren R, Ligumsky M (1994). Indomethacin-induced colonic ulceration and bleeding. Ann. Pharmacother. 28: 883-885.
32. Parkhouse J, Pleuvry BJ (1979). Analgesic drugs. Blackwell Co., Oxford. p. 1
33. th Edn. Goodman and Gilman's the pharmacological basis of therapeutics. McGraw Hill Co., New York, p. 687-731.
34. Rogers ME, Maisels F, Williamson EA, Fernandez M, Tutin CE (1990). The diet of gorillas in the Lope Reserve, Gabon: a nutritional analysis. Oecologia. 84:326-339.
35. th Edn. Goodman and Gilman's the pharmacological basis of therapeutics. McGraw Hill Co., New York, p. 1649-1677.
36. Sharma KK, Khanna T, Sen P (1982). Current status of centrally acting peptides. In: (Dhawan, BN, ed) Advances in Biosciences Vol 38, Oxford: Pergamon Press, p. 147.
37. Vane JR (1971).Inhibition of prostaglandin synthesis as a mechanism of action for aspririn-like drugs. Nat. New Biol. 231: 232-235.
38. Vane JR, Bolting RM (1995). New insights into the mode of action of anti-inflammatory drugs. Inflamm. Res. 44(1):1-10.
39. Viana GSB, Bandeira MAM, Moura LC, Souza-Filho MVP, Matos FJA, Ribeiro RA (1997). Analgesic and anti-inflammatory effects of the tannin fraction from Myracrodroun urundeuva Fr. All. Phytother. Res. 11:118-122.
40. Winter CA, Risley EA, Nuss GW (1962). Carrageenin-induced oedema in hind limb paw of the rat as an assay for anti-inflammatory drugs. Proc. Soc. Exp. Biol. 111:544-557.
41. Witzgall H, Scherer B, Weber PC (1982). Involvement of prostaglandins in the actions of captopril. Clin. Sci. 63:265S-267S.
42. Yoshimoto A, Ito H, Tomita K (1970). cofactor requirements of the enzyme synthesizing prostaglandin in bovine serninal vesicles. J. Biochem. 68: 487-499.